Extracellular vesicles (EVs) are cell-to-cell communication vehicles and mediators of numerous physiological and pathological mechanisms. Because EVs reach their intended targets with greater specificity than many existing pharmaceuticals, researchers are interested in their potential as therapeutic delivery vectors. However, consistently producing clinical-grade EVs in high quantities requires that EV production takes place in physiologically-relevant environments. 3-D production systems such as hollow fiber bioreactors (HFBRs) offers scientists the ability to generate high-quality EVs for research and therapeutic applications.
Download this application note from FiberCell Systems to learn about HFBRs, how to use them to produce EVs, and the throughputs and quality that they help achieve.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.